Detection of contamination with antineoplastic agents in a hospital pharmacy department.
about
Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer deviceSurface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: methodology and recommendationsImpact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospitalHazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing processReduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer DeviceOccupational exposure to chemotherapy of pharmacy personnel at a single centreA probabilistic assessment of the impact of interventions on oncology nurses' exposure to antineoplastic agentsA study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products.Occupational exposure to cytotoxic drugs in two UK oncology wards.Pilot Evaluation of Dermal Contamination by Antineoplastic Drugs among Hospital Pharmacy Personnel.Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug.Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.Guidance values for surface monitoring of antineoplastic drugs in German pharmacies.Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital.Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents.New approaches to wipe sampling methods for antineoplastic and other hazardous drugs in healthcare settings.
P2860
Q23919324-D8CB7D8F-CAB8-4008-BC46-D1FDAF9DDD4EQ23922577-CABEBACF-DE4B-41B9-8123-4FBEB6B0236BQ28384936-17AE37D0-47CB-44F7-9AE7-7A876C4137D3Q28388219-8106E3D6-387C-40E3-90F1-FA5C2F1435A0Q28391685-543AEDB4-762F-4DE7-A17E-D09C7A16E6D4Q28392801-0202D940-3599-4626-9CD2-7492F3F4B3CAQ28397365-0046489E-1551-4FA6-8A58-71DB2599B287Q33857689-50FD739E-AF32-404F-8054-9651FB2F325BQ35177036-1DE46682-E5BE-4023-8FB7-0B838BC5342EQ35496593-8F9903D9-54BD-4E82-A897-8F4F6DDBEE79Q38860229-776F02AE-1A0D-4B4C-B68C-1FCEBFBCFBC0Q39898348-57DCA7D8-5FEF-43E7-908B-CBC947FEF6FCQ44179920-2EC82119-AA6E-4BF7-A000-9E97EB3EAFE6Q45182465-6FF5A498-70CE-44ED-B0A3-210A8A223EC1Q45793954-3B70A7D8-8CBB-4CA0-9DDA-0F0D2E515CA6Q46688685-7197DF4B-40D1-4806-9C93-5FB9A29B199DQ54328762-48F38898-7477-446F-8FF4-2DFFC934B1CF
P2860
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
@en
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
@nl
type
label
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
@en
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
@nl
prefLabel
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
@en
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
@nl
P2093
P356
P1476
Detection of contamination with antineoplastic agents in a hospital pharmacy department.
@en
P2093
Sessink PJ
Van den Broek PH
P2860
P356
10.1007/BF01989220
P577
1992-02-01T00:00:00Z